![](https://d3ilqtpdwi981i.cloudfront.net/VRvc_e4k5BI89QDDMzyRNix18iI=/0x0:365x472/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/23/f3/4d/23f34d49-e8b9-44e6-8521-d094369850eb/1A.jpg)
Article
Resection Rate of Locally Advanced Pancreatic Cancer in Gemcitabine Plus Nab-paclitaxel versus FOLFIRINOX
Journal of Clinical Oncology
(2021)
Disciplines
Publication Date
2021
Citation Information
Ripal Gandhi, Shahriar Sharif, Amer H. Zureikat, Paula M. Novelli, et al.. "Resection Rate of Locally Advanced Pancreatic Cancer in Gemcitabine Plus Nab-paclitaxel versus FOLFIRINOX" Journal of Clinical Oncology Vol. 39 Iss. 3 Supplement (2021) p. 381 - 381 Available at: http://works.bepress.com/ripal-gandhi/453/